AR and prostate cancer: Taken together, GEMM models have characterized several genetic drivers of the Wnt pathway, gained valuable insights into the synergistic relationship between the Wnt pathway and the RAS, PI3K/PTEN, MYC, and AR signaling, and strongly implicate the Wnt cascade in prostate cancer metastasis and androgen/AR-directed therapy resistance.